Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Buy
60
IRTC Quote, Financials, Valuation and Earnings
Last price:
$135.15
Seasonality move
:
3.13%
Day range:
$131.81 - $135.85
52-week range:
$55.92 - $137.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.85x
P/B ratio:
49.80x
Volume:
805.9K
Avg. volume:
466.7K
1-year change:
26.54%
Market cap:
$4.3B
Revenue:
$591.8M
EPS (TTM):
-$3.14
Analysts' Opinion
-
Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $137.33, iRhythm Technologies has an estimated upside of 1.59% from its current price of $135.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $127.00 representing 6.05% downside risk from its current price of $135.18.
Fair Value
-
According to the consensus of 10 analysts, iRhythm Technologies has 1.59% upside to fair value with a price target of $137.33 per share.
IRTC vs. S&P 500
-
Over the past 5 trading days, iRhythm Technologies has overperformed the S&P 500 by 26.7% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
iRhythm Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
iRhythm Technologies has grown year-over-year revenues for 19 quarters straight. In the most recent quarter iRhythm Technologies reported revenues of $158.7M.
Earnings Growth
-
iRhythm Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter iRhythm Technologies reported earnings per share of -$0.97.
Enterprise value:
4.4B
EV / Invested capital:
6.05x
Price / LTM sales:
6.85x
EV / EBIT:
--
EV / Revenue:
7.18x
PEG ratio (5yr expected):
-0.57x
EV / Free cash flow:
-4,202.75x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$429.2M
Return On Assets:
-10.7%
Net Income Margin (TTM):
-15.9%
Return On Equity:
-112.03%
Return On Invested Capital:
-13.41%
Operating Margin:
-20.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $430M | $513.2M | $618.6M | $131.9M | $158.7M | |
| Gross Profit | $295.6M | $343.6M | $429.2M | $87.5M | $109.2M | |
| Operating Income | -$104.7M | -$112.7M | -$109.3M | -$38.1M | -$32.6M | |
| EBITDA | -$86.4M | -$100.1M | -$58.7M | -$36.4M | -$21M | |
| Diluted EPS | -$3.47 | -$4.23 | -$3.14 | -$1.47 | -$0.97 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $336.1M | $286.4M | $253.9M | $687.5M | $636M | |
| Total Assets | $478.5M | $428.7M | $421.7M | $909.8M | $926.1M | |
| Current Liabilities | $59.4M | $61.8M | $81.9M | $96.8M | $111.3M | |
| Total Liabilities | $168.9M | $183.9M | $199.9M | $819.5M | $839.4M | |
| Total Equity | $309.6M | $244.8M | $221.8M | $90.3M | $86.7M | |
| Total Debt | $30.1M | $34.9M | $34.9M | $644.1M | $647.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$14.9M | -$71.4M | $47.5M | -$52M | -$7.9M | |
| Cash From Investing | -$40.1M | $35M | -$201.1M | $40M | -$38.1M | |
| Cash From Financing | $13M | $512.6M | $8.5M | $504.6M | $1.7M | |
| Free Cash Flow | -$47.6M | -$113.2M | -$1.1M | -$61.8M | -$17.3M | |
IRTC
Sector
Market Cap
$4.3B
$35.1M
Price % of 52-Week High
98.32%
44.56%
Dividend Yield
0%
0%
Shareholder Yield
-3.67%
-0.74%
1-Year Price Total Return
26.54%
-40.62%
Beta (5-Year)
1.343
0.662
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$117.10
200-day SMA
Buy
Level
$89.46
Bollinger Bands (100)
Buy
Level
93.17 - 112.97
Chaikin Money Flow
Buy
Level
31.8M
20-day SMA
Buy
Level
$107.42
Relative Strength Index (RSI14)
Buy
Level
80.49
ADX Line
Buy
Level
24.28
Williams %R
Sell
Level
-5.7277
50-day SMA
Buy
Level
$106.23
MACD (12, 26)
Buy
Level
6.17
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
14M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.8505)
Sell
CA Score
(Annual)
Level (-2.0675)
Buy
Beneish M-Score
(Annual)
Level (-3.4863)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.9398)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Stock Forecast FAQ
In the current month, IRTC has received 9 Buy ratings 1 Hold ratings, and 0 Sell ratings. The IRTC average analyst price target in the past 3 months is $137.33.
-
Where Will iRhythm Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that iRhythm Technologies share price will rise to $137.33 per share over the next 12 months.
-
What Do Analysts Say About iRhythm Technologies?
Analysts are divided on their view about iRhythm Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iRhythm Technologies is a Sell and believe this share price will drop from its current level to $127.00.
-
What Is iRhythm Technologies's Price Target?
The price target for iRhythm Technologies over the next 1-year time period is forecast to be $137.33 according to 10 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is IRTC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for iRhythm Technologies is a Buy. 9 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of IRTC?
You can purchase shares of iRhythm Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iRhythm Technologies shares.
-
What Is The iRhythm Technologies Share Price Today?
iRhythm Technologies was last trading at $135.15 per share. This represents the most recent stock quote for iRhythm Technologies. Yesterday, iRhythm Technologies closed at $135.18 per share.
-
How To Buy iRhythm Technologies Stock Online?
In order to purchase iRhythm Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 29.67% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is up 0.19% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 16.94% over the past day.
